Welcome to International Network for Natural Sciences | INNSpub

A review on advancement towards hepatitis c virus genotyping and novel assays approach for determination of HCV Genotypes

Review Paper | December 1, 2019

| Download 4

Hafiz Muhammad Imran, Bahzad Ahmad Farhan, Sidra Akram, Mubara Saeed, Kainat Anwer, Amina Sehar, Maryam Aslam, Asfoora Azmat, Muhammad Zulqarnain Haider

Key Words:

Int. J. Biosci.15( 6), 420-440, December 2019

DOI: http://dx.doi.org/10.12692/ijb/15.6.420-440


IJB 2019 [Generate Certificate]


HCV is an epidemic pathogen worldwide and thousands of people die each year by infectious effects of HCV which is ultimately effect liver and damage liver functioning by liver cirrhosis. Currently, vaccine for HCV is not developed due to its 6 major genotypes and more than 67 subtypes. Therefore, for each viral genotype treatment is different. HCV is globally distributed in the world. Thus, each viral genotypes and subtypes are widespread in the particular areas of world. In Pakistan, the most prevalent subtype of HCV is 3a. There is a great challenge for identification of type of viral genotype in each patient for proper treatment of viral infection. Therefore, different types of assays are used for determination of type of viral infection. Nucleotide sequencing method for genotype and subtype determination is an appropriate method for diagnosis which require sequencing of whole genome of HCV, but this method is more expensive and time consuming. Versant assay or Line Probe assay (LiPA), Sentosa SQ HCV genotyping assay, HCV genotyping 9G test and Cobas HCV genotyping are appropriate and less time-consuming method of screening of HCV genotyping and can be suitable and can meet whole requirements of identification of type of viral infection.


Copyright © 2019
By Authors and International Network for
Natural Sciences (INNSPUB)
This article is published under the terms of the Creative
Commons Attribution Liscense 4.0

A review on advancement towards hepatitis c virus genotyping and novel assays approach for determination of HCV Genotypes

Chantratita W, Song KS, Nimse SB, Pongthanapisith V, Thongbaiphet N, Wongtabtim G, Pasomsub E, Angkanavin K, Sonawane MD, Warkad SD, Kim T. 2017. 6 HCV Genotyping 9G test for HCV 1a, 1b, 2, 3, 4 and 6 (6a, 6f, 6i and 6n) with high accuracy. Journal of virological methods 246, 95-99.

Chen SL, Morgan TR. 2006. The natural history of hepatitis C virus (HCV) infection. International journal of medical sciences 3(2), 47.

Chevaliez S, Pawlotsky JM. 2006. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. International journal of medical sciences 3(2), 35.

Chueca N, Rivadulla I, Lovatti R, Reina G, Blanco A, Fernandez-Caballero JA, Cardeñoso L, Rodriguez-Granjer J, Fernandez-Alonso M, Aguilera A, Alvarez M. 2016. Using NS5B sequencing for hepatitis C virus genotyping reveals discordances with commercial platforms. PLoS One 11(4), e0153754.

Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, DuCros Ford N. 2013. Viral hepatitis and the G lobal B urden of D isease: a need to regroup. Journal of viral hepatitis 20(9), 600-601.

Cunningham EB, Applegate TL, Lloyd AR, Dore GJ, Grebely J. 2015. Mixed HCV infection and reinfection in people who inject drugs—impact on therapy. Nature reviews Gastroenterology & hepatology 12(4), 218.

De Francesco R, Tomei L, Altamura S, Summa V, Migliaccio G. 2003. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Research 58(1), 1-16.

Doss W, Shiha G, Hassany M, Soliman R, Fouad R, Khairy M, Doehle B. 2015. Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4. Journal of hepatology 63(3), 581-585.

El Kassas M, Elbaz T, Hafez E, Esmat G. 2016. Safety of direct antiviral agents in the management of hepatitis C. Expert opinion on drug safety 15(12), 1643-1652.

Fakhr AE, Pourkarim MR, Maes P, Atta AH, Marei A, Azab M, Van Ranst M. 2013. Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients from the Sharkia Governorate, Egypt. Hepatitis monthly 13(12).

Fan W, Zhu W, Wei L, Wang Q, Yin L, Du S, Zhuang H. 2005. Nonstructural 5A gene variability of hepatitis C virus (HCV) during a 10-year follow up. Journal of gastroenterology 40(1), 43-51.

Farshadpour F, Makvandi M, Samarbafzadeh AR, Jalalifar MA. 2010. Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. Indian Journal of Medical Microbiology 28(1), 54.

Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, Mazzotta F. 2015. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection. New England Journal of Medicine 373(27), 2599-2607.

Fernández-Caballero JA, Alvarez M, Chueca N, Pérez AB, García F. 2017. The cobas® HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice. PloS one 12(4), e0175564.

Firdaus R, Saha K, Biswas A, Sadhukhan PC. 2015. Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review. World journal of virology 4(1), 25.

Germer JJ, Rys PN, Thorvilson JN, Persing DH. 1999. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. Journal of clinical microbiology 37(8), 2625-2630.

Ghani U, Naeem M Bukhari SSH, Yar G, Tariq I, Siddique S, Nawaz HA, Pal ZAA, Nasim F, Bukhari SAH. 2019. Prevalence and Risk Factors associated with Hepatitis B and Hepatitis C and their Correlation with Inflammatory Markers among Southern Region of Punjab. Biological Forum – An International Journal 11(2), 136-143.

Golemba MD, Culasso AC, Villamil FG, Bare P, Gadano A, Ridruejo E, Martinez A, Di Lello FA, Campos RH. 2013. Hepatitis C virus diversification in Argentina: comparative analysis between the large city of Buenos Aires and the small rural town of O’Brien. PloS one 8(12), e84007.

Gryadunov D, Nicot F, Dubois M, Mikhailovich V, Zasedatelev A, Izopet J. 2010. Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence. Journal of clinical microbiology 48(11), 3910-3917.

Halfon P, Trimoulet P, Bourliere M, Khiri H, De Ledinghen V, Couzigou P, Ouzan D. 2001. Hepatitis C virus genotyping based on 5′ noncoding sequence analysis (Trugene). Journal of clinical microbiology 39(5), 1771-1773.

Hua R, Jiang X, Qi L, Guan S, Kuai Z, Qiao Y, Xu Y, Gong X, Shi Y, Kong W, Niu J. 2018. Screening HCV genotype-specific epitope peptides based on conserved sequence analysis and B cell epitope prediction in HCV E2 region. Immunologic research 66(1), 67-73.

Islam MS, Miah MR, Roy PK, Rahman O, Siddique AB, Chowdhury J, Ahmed F, Rahman, Khan MR. 2015. Genotypes of hepatitis C virus infection in Bangladeshi population. Mymensingh medical journal: MMJ 24(1), 143-151.

Ismail SA, Cuadros DF, Benova L. 2017. Hepatitis B in Egypt: a cross‐sectional analysis of prevalence and risk factors for active infection from a nationwide survey. Liver international 37(12), 1814-1822.

Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L, Crivellaro C, Sokal E, Azzari C, Guido M, Bortolotti F. 2003. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clinical infectious diseases 36(3), 275-280.

Kandeel A, Genedy M, ElRefai S, Funk AL, Fontanet A, Talaat M. 2017. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment. Liver International 37(1), 45-53.

Khan AG, Whidby J, Miller MT, Scarborough H, Zatorski AV, Cygan A, Price AA, Yost SA, Bohannon CD, Jacob J, Grakoui A. 2014. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature 509(7500), 381.

Khan N, Akmal M, Hayat M, Umar M, Ullah A, Ahmed I, Saleha S. 2014. Geographic distribution of hepatitis C virus genotypes in pakistan. Hepatitis monthly 14(10).

Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Ørum H. 2010. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962), 198-201.

Laperche S, Lunel F, Izopet J, Alain S, Dény P, Duverlie G, Thibault V. 2005. Comparison of hepatitis C virus NS5b and 5′ noncoding gene sequencing methods in a multicenter study. Journal of clinical microbiology 43(2), 733-739.

Larrat S, Poveda JD, Coudret C, Fusillier K, Magnat N, Signori-Schmuck A, Morand P. 2013. Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA) 2.0. Journal of clinical microbiology JCM-00586.

Lavanchy D. 2011. Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection 17(2), 107-115.

Lee MH, Yang HI, Yuan Y, L’Italien G, Chen CJ. 2014. Epidemiology and natural history of hepatitis C virus infection. World journal of gastroenterology: WJG 20(28), 9270.

 Lefrère JJ, Pawlotsky JM, De P, Chevaliez S, Portal C, Razer A, Cantaloube JF. Improvement of Hepatitis C Virus (HCV).

Li HC, Lo SY. 2015. Hepatitis C virus: Virology, diagnosis and treatment. World journal of hepatology 7(10), 1377.

Li Y, Yamane D, Masaki T, Lemon SM. 2015. The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA. Nat. Revolution. Microelectronics 13 544–558.

Mahajan S, Choudhary MC, Kumar G, Gupta E. 2018. Evaluation of dried blood spot as an alternative sample collection method for hepatitis C virus RNA quantitation and genotyping using a commercial system. VirusDisease 29(2), 141-146.

Maheshwari A, Thuluvath PJ. 2010.  Management of acute hepatitis C. Clinics in liver disease 14(1), 169-176.

Manee N, Thongbaiphet N, Pasomsub E, Chantratita W. 2017. Clinical evaluation of a newly developed automated massively parallel sequencing assay for hepatitis C virus genotyping and detection of resistance-association variants. Comparison with a line probe assay. Journal of virological methods 249, 31-37.

Marcellin P, Boyer N. 2003. Chronic viral hepatitis. Best Practice Research Clinical Gastroenterology 17(2), 259-275.

Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. 2015. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61(1), 77-87.

Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, Sabbah S. 2007. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. Journal of clinical microbiology 45(4), 1102-1112.

Naeem M, Hayat M, Qamar SA, Mehmood T, Munir A, Ahmad G, Azmi UR, Faryad MA, Talib MZ, Irfan M, Hussain A, Hayder MA, Ghani U, Mehmood F. 2019. Risk factors, genetic mutations and prevention of breast cancer. International Journal of Biosciences 14(4), 492-496.

Naeem M. 2019.Principles of Biochemistry and Biological Sciences. Nishtar Publications (Pvt).Ltd.p 138

Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M. 2012. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver international 32(2), 339-345.

Nakatani SM, Santos CA, Riediger IN, Krieger MA, Duarte CA, do Carmo Debur M, Ono SK. 2011. Comparative performance evaluation of hepatitis C virus genotyping based on the 5’untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C. Virology journal 8(1), 459.

Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. 2011. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. The Lancet 378(9791), 571-583.

Nimse SB, Song KS, Kim J, Ta VT, Nguyen VT, Kim T. 2011. A generalized probe selection method for DNA chips. Chemical Communications 47(46), 12444-12446.

Nouroz F, Shaheen S, Mujtaba G, Noreen S. 2015. An overview on hepatitis C virus genotypes and its control. Egyptian Journal of Medical Human Genetics 16(4), 291-298.

Pham VH, Nguyen HD, Ho PT, Banh DV, Pham HL, Pham PH, Abe K. 2011. Very high prevalence of hepatitis C virus genotype 6 variants in southern Vietnam: large-scale survey based on sequence determination. Japanese journal of infectious diseases 64(6), 537.

Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Perno CF. 2016. Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district. Clinico Economics and outcomes research: CEOR 8, 467.

Qiu P, Stevens R, Wei B, Lahser F, Howe AY, Klappenbach JA, Marton MJ. 2015. HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma. PLoS One 10(4), e0122082.

Schutzbank TE, Sefers SE, Kahmann N, Li H, Tang YW. 2006. Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping. Journal of clinical microbiology 44(10), 3797-3798.

Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. 2014. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology  59(1), 318-327.

Song K. S, Nimse SB, Kim J, Sayyed DR, & Kim T. 2013. A new platform for a convenient genotyping system. Chemical Communications  49(26), 2661-2663.

Stelzl E, Appel HM, Mehta R, Marins EG, Berg J, Paar C, Kessler HH. 2017. Evaluation of the new cobas® HCV genotyping test based on real-time PCRs of three different HCV genome regions. Clinical Chemistry and Laboratory Medicine (CCLM) 55(4), 517-521.

Tong YQ, Liu B, Liu H, Zheng HY, Gu J, Song EJ, Li Y. 2015. Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population. Clinical Microbiology and Infection 21(9), 874-e9.

Usman G, Ammara B, Hamza R, Muhammad N, Syed SHB, Hafiz A, Amna N, Sara S, Shahid AC. 2019.Saudi Advancement and Future Directions towards Herbal Treatment for Various Diseases. Saudi Journal of Medical and Pharmaceutical Sciences 5(11), 931-941

Usman G, Muhammad N, Hamza R, Usman I, Ayesha A, Saqib U, Asim R, Fatima Q. 2019. A Novel Approach towards Nutraceuticals and Biomedical Applications. Scholars International Journal of Biochemistry 2(10), 245-252.

Verbeeck J, Stanley MJ, Shieh J, Celis L, Huyck E, Wollants E, Schaper C. 2008. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. Journal of clinical microbiology 46(6), 1901-1906.

Wasitthankasem R, Vongpunsawad S, Siripon N, Suya C, Chulothok P, Chaiear K, Poovorawan Y. 2015. Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia. PloS one 10(5), e0126764.

Weck K. 2005. Molecular methods of hepatitis C genotyping. Expert review of molecular diagnostics 5(4), 507-520.

Yamada H, Fujimoto M, Svay S, Lim O, Hok S, Goto N, Katayama K. 2015. Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in S iem R eap, C ambodia. Hepatology Research 45(4), 480-487.

Yang R, Cong X, Du S, Fei R, Rao H, Wei L. 2014. Performance comparison of the Versant HCV Genotype 2.0 Assay (LiPA) and the Abbott Realtime HCV Genotype II for detecting hepatitis C virus Genotype 6. Journal of clinical microbiology JCM-00882.

Yusrina F, Chua CW, Lee CK, Chiu L, Png TSY, Khoo MJ, Lee HK. 2018. Comparison of cobas HCV GT against Versant HCV Genotype 2.0 (LiPA) with confirmation by Sanger sequencing. Journal of virological methods 255, 8-13.